Comprehensive safety information for Mebendazole 500mg
Mebendazole 500mg has a well-established safety profile with over 40 years of clinical use. It is generally well-tolerated with most adverse events being mild and transient. The benefit-risk ratio is favorable for approved indications.
Frequency and severity of side effects
>1% of patients
<1% of patients
Conditions where Mebendazole should not be used
Known allergy to mebendazole or any benzimidazole derivatives. May cause severe allergic reactions including anaphylaxis.
Teratogenic effects demonstrated in animal studies. Avoid use during first trimester of pregnancy.
Metabolism may be significantly impaired, leading to increased systemic exposure and toxicity risk.
Safety and efficacy not established. Use only under strict medical supervision.
Important safety considerations for use
Use only if benefits clearly outweigh risks. Requires medical supervision.
Small amounts excreted in breast milk. Use with caution under medical supervision.
Use with caution. Monitor liver function tests during treatment.
Contraindicated. Alternative treatments should be considered.
May increase mebendazole plasma levels. Monitor for increased side effects.
Rare severe reactions reported. Avoid concurrent use if possible.
May reduce mebendazole efficacy. Consider alternative treatment.
Generally well-tolerated but may have increased sensitivity to side effects.
Closer monitoring recommended for adverse events and drug interactions.
Potential interactions with other medications
| Interacting Drug | Interaction Type | Effect | Management |
|---|---|---|---|
| Cimetidine | Moderate | Increased mebendazole levels | Monitor for side effects |
| Metronidazole | Severe | Rare severe reactions | Avoid concurrent use |
| Phenytoin | Moderate | Reduced mebendazole efficacy | Consider alternative |
| Carbamazepine | Moderate | Reduced mebendazole efficacy | Consider alternative |
| Rifampin | Moderate | Reduced mebendazole levels | Monitor efficacy |
| Anticoagulants | Minor | Potential additive effects | Monitor INR/PT |
Safety considerations for specific patient groups
Generally well-tolerated in children >2 years. Side effects similar to adults but may be more pronounced.
Similar to younger adults but may have increased sensitivity to side effects.
Similar efficacy but may require closer monitoring for adverse events.
How to report side effects and safety concerns
Ongoing safety surveillance and monitoring
Mebendazole 500mg maintains a favorable safety profile with over 40 years of clinical use. The benefits of treating parasitic infections generally outweigh the risks for approved indications. Continuous pharmacovigilance ensures ongoing safety assessment.
Access complete safety information and reporting resources
Our team is ready to provide you with the best pharmaceutical products and support